CEOs Cannot Delegate AI Strategy Anymore
There was a version of technology strategy that a CEO could mostly delegate.
The company needed a CRM. A data warehouse. A mobile app. A cloud migration. Better analytics. Security tooling. The CEO still needed to care, but the work could often live inside IT, product, engineering, or operations.
AI is different.
Not because it is more fashionable. Because it touches the structure of the firm.
AI changes how work gets done, how knowledge compounds, how customers experience the product, how employees make decisions, how data becomes intelligence, and how competitive advantage is protected or lost.
That means AI strategy cannot just be a vendor relationship.
It has to be CEO-level thinking.
Press Releases Are Not Strategy
A lot of companies treat AI strategy as a partnership announcement.
They launch a chatbot. They say they are using a frontier model. They announce a few agents. They create an internal task force. They add AI to the roadmap.
None of that is bad.
But none of it is enough.
The question is not "do we have AI features?"
The question is "how does AI change the economics, operating model, and defensibility of this company?"
That is a much harder question. It cannot be answered by a demo.
The CEO Needs a View of the AI Stack
I do not think every CEO needs to become an ML researcher.
But every CEO now needs a real mental model of the AI stack.
What models do we depend on? What data do we expose? What workflows are being automated? What internal knowledge is being captured? What do we own? What do our vendors learn from us? What happens if model costs change? Where do we need frontier intelligence, and where do we need a smaller, cheaper, specialized system?
These are strategic questions.
They affect margin, speed, hiring, product quality, customer trust, compliance, and long-term differentiation.
If the CEO does not understand the stack, the company will drift into an AI strategy by accident.
And accidental strategy is usually just vendor strategy wearing your company logo.
AI Changes the Firm, Not Just the Tooling
The biggest shift is that AI is not only improving tools. It is changing the shape of work.
If agents can do research, write code, process claims, draft clinical documentation, analyze support tickets, generate marketing experiments, and coordinate operational tasks, then the company needs to rethink roles, workflows, permissions, review loops, and accountability.
Who owns the output of an agent?
Who reviews it?
What can it access?
What should it never do?
How does the company learn from the work?
How does the human stay in control without becoming a bottleneck?
Those are operating model questions. They are not side projects.
The Hard Part Is Judgment
The easy version of AI adoption is giving everyone a tool.
The hard version is deciding where intelligence should live in the company.
Should this workflow be automated or augmented?
Should this be handled by a frontier model, a smaller model, rules, or a human?
Should the company build, buy, fine-tune, or partner?
Should the data stay inside the company?
What is the customer's tolerance for error?
What new risks are we creating?
What work becomes more valuable when AI makes execution cheaper?
These are judgment calls. They require business context, technical understanding, customer empathy, and a point of view about the future.
That is exactly the CEO's job.
AI Capital Needs Ownership
If companies are going to build token capital, someone has to own it.
Not in the narrow sense of platform ownership. In the strategic sense.
What proprietary intelligence are we creating? What learning loops are we building? What internal knowledge is becoming reusable? What workflows are becoming more efficient every week? What expertise are we protecting? What capabilities are we giving away?
I think this will become one of the most important leadership conversations in companies.
Human capital has always been a CEO concern.
AI capital should be too.
This Is Especially True in Healthcare
Healthcare makes this obvious because the stakes are high and the workflows are complex.
A hospital, clinic, pharmacy, imaging company, or healthtech startup cannot treat AI as a generic productivity layer. The work is full of privacy constraints, clinical nuance, liability, trust, reimbursement, operational friction, and human emotion.
The CEO has to understand where AI can safely remove burden and where it must stay bounded.
The goal is not to replace clinical judgment. The goal is to give clinicians more time, better tools, cleaner workflows, and less administrative drag.
That requires strategy, not just implementation.
The New CEO Question
The CEO question used to be:
How do we use software to become more efficient?
Now it is becoming:
How do we make the company itself more intelligent?
That question touches product, operations, data, security, finance, hiring, customer experience, and culture.
It is too central to delegate completely.
The best leaders will not be the ones who pretend to know every technical detail. They will be the ones who get close enough to the technology to make real strategic decisions.
AI is becoming part of the firm.
And the structure of the firm is always the CEO's job.